SantoshSarafMD

PubMed

• 19 citations
  Systematic Review of Crizanlizumab: a New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease
  Jin Han, Santosh L. Saraf, Victor R. Gordeuk
  Pharmacotherapy. 2020-06-01
• 33 citations
  Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.
  Pritesh R. Patel, Bulent Aydogan, Dolores Mahmud, Annie Oh, Santosh L. Saraf
  Biology of Blood and Marrow Transplantation. 2014-12-01
• 4 citations
  Improvement of hemolytic anemia with GBT1118 is renoprotective in transgenic sickle mice.
  Guohui Ren, Suman Setty, Xu Zhang, Alexandru Susma, Maria Armila Ruiz
  Blood Advances. 2022-08-09

Abstracts/Posters

• Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell Disease
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Biomarkers of Cardiopulmonary, Renal, and Liver Dysfunction in an Adult Sickle Cell Disease Cohort
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thrombomodulin and Endothelial Dysfunction in Sickle Cell Anemia
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomize...
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia
  Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Laboratory and Translational Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Regulatory Genetic Variation at the S100B Gene Associates with Vaso-Occlusive Manifestations in Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Cancer Incidence in Sickle Cell Disease:an Institutional Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all